| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
5.6 An online portal to evidence-based toxicology
|
Kinsner, A
|
|
2009
|
|
2-3 |
p. 161-161
|
artikel
|
| 2 |
4.2 Applying an evidence-based approach: arsenic as a health risk
|
Silbergeld, E
|
|
2009
|
|
2-3 |
p. 127-129
|
artikel
|
| 3 |
1.2 Aspects of test assessment
|
Hoffmann, S
|
|
2009
|
|
2-3 |
p. 95-96
|
artikel
|
| 4 |
4.7 Biological modeling as a method for data evaluation and integration in toxicology
|
Barton, HA
|
|
2009
|
|
2-3 |
p. 143-145
|
artikel
|
| 5 |
Clear path: towards an evidence-based toxicology (EBT)
|
Guzelian, PS
|
|
2009
|
|
2-3 |
p. 71-79
|
artikel
|
| 6 |
1.4 Comparing medicine with toxicology – a mapping of knowledge creation, concepts and basic epistemology
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 101-104
|
artikel
|
| 7 |
6 Conclusions
|
Kimber, I
|
|
2009
|
|
2-3 |
p. 163-163
|
artikel
|
| 8 |
1.3 Consensus, opinion, and evidence-based science – three methods of reaching conclusions in toxicology
|
Guzelian, P
|
|
2009
|
|
2-3 |
p. 97-99
|
artikel
|
| 9 |
3. Core problems and case studies
|
Cebrián, ME
|
|
2009
|
|
2-3 |
p. 113-113
|
artikel
|
| 10 |
4.9 Current information sources for hazard identification
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 149-149
|
artikel
|
| 11 |
4.8 Current schemes for decision-making in toxicology
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 147-147
|
artikel
|
| 12 |
2.2 Evidence-based health care and the Cochrane Collaboration
|
Scherer, RW
|
|
2009
|
|
2-3 |
p. 109-111
|
artikel
|
| 13 |
4.5 Evidence-based individual toxicological analysis
|
Guzelian, P
|
|
2009
|
|
2-3 |
p. 136-138
|
artikel
|
| 14 |
2. Evidence-based medicine – a possible model for evidence-based toxicology?
|
Neugebauer, EAM
|
|
2009
|
|
2-3 |
p. 105-107
|
artikel
|
| 15 |
5.3 Evidence-based tools in toxicological decision-making
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 155-155
|
artikel
|
| 16 |
5.2 Evidence-based tools in toxicological hazard identification
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 153-153
|
artikel
|
| 17 |
1 Fundamentals of a an evidence-based toxicology
|
Hartung, T
|
|
2009
|
|
2-3 |
p. 93-94
|
artikel
|
| 18 |
Greeting
|
Galli, CL
|
|
2009
|
|
2-3 |
p. 81-81
|
artikel
|
| 19 |
4.3 In-vitro genotoxicity tests to detect carcinogenicity: a systematic review
|
Müller, L
|
|
2009
|
|
2-3 |
p. 131-133
|
artikel
|
| 20 |
5.4 Possible improvement of information sources on hazard and risk
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 157-157
|
artikel
|
| 21 |
Preface
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 83-86
|
artikel
|
| 22 |
3.2 Quantification of uncertainty within and between species and the role of uncertainty factors
|
Edler, L
|
|
2009
|
|
2-3 |
p. 115-117
|
artikel
|
| 23 |
5.5 Standardization: an efficient tool to support evidence-based toxicology
|
Pirlet, A
|
|
2009
|
|
2-3 |
p. 159-159
|
artikel
|
| 24 |
5 Steps toward an evidence-based toxicology
|
Griesinger, C
|
|
2009
|
|
2-3 |
p. 151-151
|
artikel
|
| 25 |
4.4 The proposed replacement of the no observed adverse effect level with benchmark dose levels in food risk assessment
|
Edler, L
|
|
2009
|
|
2-3 |
p. 135-135
|
artikel
|
| 26 |
4.6 Toxicogenomics and biology-based modeling framework for health risk assessment
|
Sarigiannis, D
|
|
2009
|
|
2-3 |
p. 139-141
|
artikel
|
| 27 |
4 Toxicological decision-making on hazards and risks – status quo and way forward
|
Portier, C
|
|
2009
|
|
2-3 |
p. 123-125
|
artikel
|
| 28 |
3.3 Trovafloxacin: a case study of idiosyncratic or iatrogenic liver toxicity – molecular mechanisms and lessons for pharmacotoxicity
|
Borlak, J
|
|
2009
|
|
2-3 |
p. 119-121
|
artikel
|
Tijdschrift beschrijving